Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24h of symptom onset

Lam, Nicole Y.-L., Rainer, Timothy ORCID: https://orcid.org/0000-0003-3355-3237, Wong, Lawrence K.-S., Lam, Wynnie and Lo, Y.-M. Dennis 2006. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24h of symptom onset. Resuscitation 68 (1) , pp. 71-78. 10.1016/j.resuscitation.2005.05.021

Full text not available from this repository.

Abstract

Modern neuroimaging safely and reliably diagnoses stroke and provides information for outcome prediction. However, some patients with clinical stroke have no detectable abnormality on neuroimaging and other patients are not fit for such investigations. Therefore, we evaluated the potential of plasma DNA and serum S100 protein concentrations to predict post-stroke mortality and morbidity in patients with negative neuroimaging results. Patients with stroke-like symptoms but negative neuroimaging results were recruited. Both plasma and serum were collected from each patient for plasma DNA and serum S100 analysis. The primary outcome measures were 6-month mortality and morbidity using the post-stroke modified Rankin score (mRS). Forty-four patients were recruited to the study. Seventeen (39%) patients were classified as post-stroke mRS grades 3–6. The median plasma DNA concentration of this group of patients was significantly higher than that of patients with post-stroke mRS grades 0–2. Median serum S100 protein concentrations did not show significant differences between the two groups. Plasma DNA concentrations >800 kilogenome-equivalent/l have a sensitivity of 42% and a specificity of 100% for predicting 6-month post-stroke mRS (grades 0–2), with an area under the receiver operator characteristic (ROC) curve of 0.742. By comparison, serum S100 protein concentrations >0.09 μg/l have a sensitivity of 48% and specificity of 75% for predicting 6-month post-stroke mRS (grades 0–2), and the area under the curve is 0.542. Plasma DNA concentration predicts post-stroke morbidity and mortality in patients with negative neuroimaging, and may be more effective than S100 protein measurement.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	Computed tomography; Magnetic resonance imaging; Plasma DNA; Post-stroke modified Rankin score; Stroke
Publisher:	Elsevier
ISSN:	0300-9572
Date of Acceptance:	25 May 2005
Last Modified:	01 Nov 2022 10:47
URI:	https://orca.cardiff.ac.uk/id/eprint/92865

Citation Data

Cited 61 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item